MERCK

Lobbying client. Federal LDA filings.

Source id: 181313
General description: A research-intensive biopharmaceutical company
State: NJ
Country: US
Principal place of business: US
Government-entity client: false
Effective date: 2015-03-01
Total spend (across 1 ingested filings): $50,000

Filings (1) — $50,000

Posted	Type	Year	Lobbying firm	Income
2026-04-20	`Q1`	2026	TARPLIN, DOWNS & YOUNG, LLC	$50,000

Connected on the graph

31 typed relationships in the influence graph — 30 inbound, 1 outbound, grouped by type.

lobbied for (24)

date	dir	entity	amount	source
—	←	Raissa H Downs	—	lda_lobbyist_client
—	←	Pamela Smith	—	lda_lobbyist_client
—	←	Elizabeth T Murray	—	lda_lobbyist_client
—	←	Emily H Murry	—	lda_lobbyist_client
—	←	Peter Fise	—	lda_lobbyist_client
—	←	Jennifer B Young	—	lda_lobbyist_client
—	←	Margaret Joseph	—	lda_lobbyist_client
—	←	Charlotte Spears Ivancic	—	lda_lobbyist_client
—	←	Parick Braerton Carroll	—	lda_lobbyist_client
—	←	Jeff Reczek	—	lda_lobbyist_client
—	←	Jeff Choudhry	—	lda_lobbyist_client
—	←	Darren Willcox	—	lda_lobbyist_client
—	←	Manny Rossman	—	lda_lobbyist_client
—	←	Corey Malmgren	—	lda_lobbyist_client
—	←	Kyle Nevins	—	lda_lobbyist_client
—	←	Jonathon Jones	—	lda_lobbyist_client
—	←	Brett Baker	—	lda_lobbyist_client
—	←	Rachel Jones Hensler	—	lda_lobbyist_client
—	←	John Michael Gonzalez	—	lda_lobbyist_client
—	←	Steve Stombres	—	lda_lobbyist_client
—	←	Mary Beth Savary Taylor	—	lda_lobbyist_client
—	←	Jonathan Slemrod	—	lda_lobbyist_client
—	←	John Leganski	—	lda_lobbyist_client
—	←	Greg D'Angelo	—	lda_lobbyist_client

lobbies for (4)

date	dir	entity	amount	source
2026-01-01	←	TIBER CREEK GROUP	$50,000	lda_filing
2026-01-01	←	W STRATEGIES, LLC	$50,000	lda_filing
2025-01-01	←	HARBINGER STRATEGIES, LLC	—	lda_filing
2025-01-01	←	THE NICKLES GROUP, LLC	—	lda_filing

co acted on bill with (2)

date	dir	entity	amount	role	source
2026-01-01	←	Murphy, Gregory F.	—	hr1492-119	lda_filing
2026-01-01	←	Murphy, Gregory F.	—	hr4299-119	lda_filing

lobbies on bill (1)

date	dir	entity	amount	role	source
2026-01-01	→	Protecting Patient Access to Cancer and Complex Therapies Act HR 4299 · introduced 2025-07-07 · latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determ…	—	H.R. 4299	lobbying_bill_mention

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.